Live feed02:40:00·710dPRReleasevia QuantisnowZealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutideByQuantisnow·Wall Street's wire, on your screen.ZEAL· Zealand Pharma A/SHealth Care
